Critical Outcome Technologies Provides Summary of Recent Achievements and Future Milestones at Annual General Meeting
Focus on the clinical development of lead compound, COTI-2, continues
(firmenpresse) - LONDON, ONTARIO -- (Marketwired) -- 10/23/14 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT)(OTCQB: COTQF), the biopharmaceutical company using machine learning to rapidly develop targeted therapies, announced today that its President & Chief Executive Officer, Dr. Wayne Danter, provided a summary of the key business achievements during the past year and an overview of plans moving forward at the Company''s Annual General and Special Meeting (AGM) of Shareholders held on Tuesday, October 21, 2014.
Highlights of the presentation included:
A copy of the full presentation can be found on COTI''s website or at .
Other highlights of the AGM included:
About Critical Outcome Technologies Inc. (COTI)
COTI is a biopharmaceutical company using machine learning to rapidly develop targeted therapies. COTI''s proprietary artificial intelligence platform, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery through chemical optimization and preclinical testing. These compounds are targeted for a variety of diseases, particularly those for which current treatments are either lacking or ineffective. For more information, visit .
Follow (at)CriticalOutcome on Twitter at
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Critical Outcome Technologies Inc.
Dr. Wayne Danter
President & CEO
519-858-5157
Heisler Communications
Trevor Heisler
Investor Relations
416-500-8061
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.10.2014 - 07:06 Uhr
Sprache: Deutsch
News-ID 1312305
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LONDON, ONTARIO
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 127 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Critical Outcome Technologies Provides Summary of Recent Achievements and Future Milestones at Annual General Meeting
"
steht unter der journalistisch-redaktionellen Verantwortung von
Critical Outcome Technologies Inc. (COTI) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
